In our previous paper (1), we discussed the in-vitro adsorption spectrum of plasma amino acids by coated charcoal hemoperfusion. We now describe the general amino acid disturbances in plasma, CSF and cerebrum in the galactosamine induced hepatic coma model in rats. All aromatic amino acids (AAA) increased significantly in the three compartments studied. Branched chain amino acids (BCAA) were either elevated to a much lesser extent or remained unchanged. The molar ratio of BCAA:AAA was consequently reduced. This is similar to findings in fulminant hepatic failure in human and other animal models. Most of the 20 amino acids analyzed were increased significantly in the plasma. Increases of amino acids were minimal in the brain tissue studied, i.e. the cerebrum.
ShiZ.Q., ChangT.M.S.: In vitro adsorption spectrum of plasma amino acids by coated charcoal hemoperfusion.Int. J. Artif. Organs,6.5, 267–270, 1983.
2.
FischerJ.E., HorstW.D., KopinI.J.: Beta-Hydroxylated sympathomimetic amines as false neurotransmitters.Brit. J. Pharmacol.,24, 477–484, 1965.
3.
ZieveL.: Metabolic abnormalities in hepatic coma and potential toxins to be removed. In: Artificial Liver Support (WilliamsR., Murray-LyonI.M., eds.) Kent: Pitman Medical, 11–26, 1974.
4.
ZieveL., DoizakiW.M., ZieveF.: Synergism between mercaptans and ammonia or fatty acids in the production of coma: A possible role for mercaptans in the pathogenesis of hepatic coma.J. Lab. Clin. Med.,83, 16, 1974.
FischerJ.E.: The role of plasma amino acids in hepatic failure.Surgery,78, 276, 1975.
7.
SmithA., Rassi-FanelliF.: Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.Ann. Surg.,187, 343–350, 1978.
8.
RecordC.O., BuxtonB., ChaseR.A., CurzonG., Murray-LyonI.M., WilliamsR.: Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy.Eur. Clin.,6, 387, 1976.
9.
FischerJ.E., YoshimuraN., AguirreA., JamesJ.H., CummingsM.G., AbelR.M., DeindoerferF.: Plasma amino acids in patients with hepatic encephalopathy: Effects of amino acid infusions.Am. J. Surg.,127, 40–47, 1974.
10.
FischerJ.E.: On the occurance of false neurochemical transmitters. In: Artificial Liver Support (WilliamsR., Murray-LyonI.M., eds.) Kent: Pitman Medical, 31, 1974.
11.
JamesJ.H., HodgmanJ.M., FischerJ.E.: Alterations in brain octopamine and brain tyrosine following portacaval anastomosis in rats.J. Neurochem.,27, 223, 1976.
12.
RecordC.O., ChaseR.A., CurzonG., Murray-LyonI.M.: Amino acid changes in hepatic encephalopathy and their relationship to disturbed cerebral neurotransmission. In: Artificial Liver Support (WilliamsR., Murray-LyonI.M., eds.) Kent: Pitman Medical, 27–30, 1974.
13.
AbounaG.M., GilchristT., PettitJ.E., BoydN.D., ToddJ.K., CourtneyJ.M., MainiR.: Hemoperfusion with activated charcoal in treatment of experimental acute hepatic failure. In: Artificial Liver Support (WilliamsR., Murray-LyonI.M., eds.) Kent: Pitman Medical, 180–185, 1974.
14.
HolminT., AgardhC.-D., AlinderG., HerlinP., HultbergB.: The influence of total hepatectomy on cerebral energy state, ammonia-related amino acids of the brain and plasma amino acids in the rat.Europ. J. Clin. Invest.,13, 215–220, 1983.
ChiritoE., ReiterB., ListerC., ChangT.M.S.: Artificial liver: The effect of ACAC microencapsulated charcoal hemoperfuion on fulminant hepatic failure.Artif. Organs,1, 76, 1977.
18.
ChiritoE., ReiterB., ListerC., ChangT.M.S.: Assessments of two rat models of fulminant hepatic failure for testing artificial liver devices. In: Artificial Kidney, Artificial Liver and Artificial Cells (ChangT.M.S., ed.) New York and London: Plenum Press, 239–243, 1977.
19.
ChiritoE., ListerC., ChangT.M.S.: Biochemical-hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.Artificial Organs,3(1), 1979.
20.
ChangT.M.S., ListerC., ChiritoE., O'KeefeP., ResurreccionE.: Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.Trans. Am. Soc. Artif. Intern. Organs,24, 243, 1978.
21.
TabataY., ChangT.M.S.: Comparison of six artificial liver support regimes in fulminant hepatic coma rats.Trans. Am. Soc. Artif. Intern. Organs,26, 384, 1980.
22.
ShuC.D., ChangT.M.S.: Tyrosinase immobilized within artificial cells for detoxification in liver failure. II. In vivo studies in fulminant hepatic failure rats.Int. J. Artif. Organs,4, 81, 1981.
23.
GelfandM.C., WinchesterJ.F., KnepshieldJ.H., CohanS.L., SchreinerG.E.: Biochemical correlates of reversal of hepatic coma with coated charcoal hemoperfusion.Trans. Am. Soc. Artif. Intern. Organs,XXIV, 239, 1978.
24.
DenisJ., DelormeM.L., BoschatM., NordlingerB., OpolonP.: Respective roles of ammonia, amino acids and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy.J. Neurochem.,40, 10–19, 1983.
25.
FosterD., AhmedK., ZieveL.: Action of methanethiol on Na+K+ATPase: Implications for hepatic coma. Ann. N.Y.Acad. Sci.,242, 573, 1974.
26.
BrunnerG., WindusG., LösgenH.: On the role of free phenols in the blood of patients in hepatic failure. In: Artificial Liver Support (BrunnerG., SchmidtF.W., eds.) Berlin Heidelberg: Springer-Verlag, 25–31, 1981.
27.
HindfeltB., PlumF., DuffyT.: Effects of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts.J. Clin. Invest.,59, 386, 1977.
28.
SourkesT.L.: Tryptophan in hepatic coma.J. Neural. Transmission, Supp.14, 79, 1978.
29.
ChangT.M.S., ListerC.: Middle molecules in hepatic coma and uremia. Artif.Organs,4(Suppl.), 169, 1980.
30.
ShuC.D., ChangT.M.S.: Middle molecules in the serum, brain and urine of galactosamine-induced hepatic failure rats. Int. J. Artif.Organs,6(5), 273–177, 1983.
31.
ShiZ.Q., ChangT.M.S.: The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats.Trans. Am. Soc. Artif. Intern. Organs,26, 205–209, 1982.
